SEC Form 4 · accession 0001209191-15-006135
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D. Clayman
Officer — President and CEO · Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 23, 2015 · 1:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $22.91 | Jan 21, 2015 | A | 110,000 | A | — | Jan 20, 2025 | Common Stock | 110,000 | 110,000 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 21, 2015; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following the one year anniversary of January 21, 2015, so that all of the shares subject to the option shall be vested four (4) years after January 21, 2015.